Celerion is the privately owned CRO formed through the acquisition of the development and regulatory services consultancy and early clinical development operations of MDS Pharma Services. Celerion applies advanced scientific and technological expertise throughout the early phases of drug development, including regulatory services, first-in-man to proof-of-concept clinical studies, bioanalysis and consultancy services.